Division of Pediatric Allergy and Immunology, Johns Hopkins School of Medicine, Baltimore, Md.
J Allergy Clin Immunol. 2013 Oct;132(4):830-5.e1-2. doi: 10.1016/j.jaci.2013.05.005. Epub 2013 Jun 26.
Cockroach and mouse allergens have both been implicated as causes in inner-city asthma morbidity in multicenter studies, but whether both allergens are clinically relevant within specific inner-city communities is unclear.
Our study aimed to identify relevant allergens in Baltimore City.
One hundred forty-four children (5-17 years old) with asthma underwent skin prick tests at baseline and had clinical data collected at baseline and 3, 6, 9, and 12 months. Home settled dust samples were collected at the same time points for quantification of indoor allergens. Participants were grouped based on their sensitization and exposure status to each allergen. All analyses were adjusted for age, sex, and serum total IgE level.
Forty-one percent were mouse sensitized/exposed, and 41% were cockroach sensitized/exposed based on bedroom floor exposure data. Mouse sensitization/exposure was associated with acute care visits, decreased FEV1/forced vital capacity percentage values, fraction of exhaled nitric oxide levels, and bronchodilator reversibility. Cockroach sensitization/exposure was only associated with acute care visits and bronchodilator reversibility when exposure was defined by using bedroom floor allergen levels. Mouse-specific IgE levels were associated with poor asthma health across a range of outcomes, whereas cockroach-specific IgE levels were not. The relationships between asthma outcomes and mouse allergen were independent of cockroach allergen. Although sensitization/exposure to both mouse and cockroach was generally associated with worse asthma, mouse sensitization/exposure was the primary contributor to these relationships.
In a community with high levels of both mouse and cockroach allergens, mouse allergen appears to be more strongly and consistently associated with poor asthma outcomes than cockroach allergen. Community-level asthma interventions in Baltimore should prioritize reducing mouse allergen exposure.
蟑螂和老鼠过敏原都被认为是多中心研究中导致城市内哮喘发病率的原因,但在特定城市社区中,这两种过敏原是否具有临床相关性尚不清楚。
我们的研究旨在确定巴尔的摩市的相关过敏原。
144 名(5-17 岁)哮喘儿童在基线时进行皮肤点刺试验,并在基线时以及 3、6、9 和 12 个月时收集临床数据。同时收集家庭定居灰尘样本,以定量室内过敏原。根据对每种过敏原的致敏和暴露情况将参与者分组。所有分析均根据年龄、性别和血清总 IgE 水平进行调整。
根据卧室地板暴露数据,41%的儿童对老鼠有过敏/暴露,41%的儿童对蟑螂有过敏/暴露。老鼠致敏/暴露与急性护理就诊、FEV1/用力肺活量百分比值降低、呼气一氧化氮水平分数和支气管扩张剂可逆性有关。当使用卧室地板过敏原水平定义蟑螂暴露时,蟑螂致敏/暴露仅与急性护理就诊和支气管扩张剂可逆性有关。鼠特异性 IgE 水平与一系列结局的哮喘健康状况较差有关,而蟑螂特异性 IgE 水平则没有。哮喘结局与鼠过敏原之间的关系独立于蟑螂过敏原。尽管对老鼠和蟑螂的致敏/暴露通常与哮喘恶化有关,但老鼠致敏/暴露是这些关系的主要贡献者。
在一个同时存在高浓度老鼠和蟑螂过敏原的社区中,老鼠过敏原似乎与较差的哮喘结局更为密切和一致相关,而蟑螂过敏原则不然。巴尔的摩的社区一级哮喘干预措施应优先减少老鼠过敏原暴露。